Literature DB >> 3528127

Immediate entrance to the export pathway after synthesis as a requirement for export of the sak gene product in Escherichia coli.

T Sako.   

Abstract

Export through the cytoplasmic membrane and processing of the sak product in Escherichia coli cells were investigated with E. coli strains carrying pTS301, which produce large amounts of staphylokinase at 42 degrees C. High-level synthesis of the sak product caused transient accumulation not only of the staphylokinase precursor (pSAK) but also of the maltose-binding protein and outer membrane protein A precursors. Thus it was concluded that the sak product shares the export pathway with E. coli secreted proteins at least at a certain step. During high-level synthesis of the sak product, a significant amount of the newly synthesized pSAK remained unprocessed after a chase period, possibly causing the observed accumulation of pSAK. Accumulating pSAK did not mature for a long period, whereas the newly synthesized sak product was exclusively detected in the mature form. These results suggest that it is necessary for the sak product to enter the export pathway during or immediately after synthesis to be exported and processed normally.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3528127      PMCID: PMC215951          DOI: 10.1128/jb.167.3.850-854.1986

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

1.  Hyperproduction of phosphate-binding protein, phoS, and pre-phoS proteins in Escherichia coli carrying a cloned phoS gene.

Authors:  T Morita; M Amemura; K Makino; H Shinagawa; K Magota; N Otsuji; A Nakata
Journal:  Eur J Biochem       Date:  1983-02-15

2.  Eukaryotic signal sequence transports insulin antigen in Escherichia coli.

Authors:  K Talmadge; S Stahl; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

3.  Protein localization in E. coli: is there a common step in the secretion of periplasmic and outer-membrane proteins?

Authors:  K Ito; P J Bassford; J Beckwith
Journal:  Cell       Date:  1981-06       Impact factor: 41.582

4.  Evidence for posttranslational translocation of beta-lactamase across the bacterial inner membrane.

Authors:  D Koshland; D Botstein
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

5.  Localization and processing of outer membrane and periplasmic proteins in Escherichia coli strains harboring export-specific suppressor mutations.

Authors:  S D Emr; P J Bassford
Journal:  J Biol Chem       Date:  1982-05-25       Impact factor: 5.157

6.  E. coli mutant pleiotropically defective in the export of secreted proteins.

Authors:  D B Oliver; J Beckwith
Journal:  Cell       Date:  1981-09       Impact factor: 41.582

7.  Different exported proteins in E. coli show differences in the temporal mode of processing in vivo.

Authors:  L G Josefsson; L L Randall
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

8.  Filamentous phage pre-coat is an integral membrane protein: analysis by a new method of membrane preparation.

Authors:  M Russel; P Model
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

9.  Identification of the signal peptidase cleavage site in Bacillus licheniformis prepenicillinase.

Authors:  C N Chang; J B Nielsen; K Izui; G Blobel; J O Lampen
Journal:  J Biol Chem       Date:  1982-04-25       Impact factor: 5.157

10.  Gene for staphylococcal protein A.

Authors:  S Löfdahl; B Guss; M Uhlén; L Philipson; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

View more
  2 in total

1.  Distinct mutation sites in prlA suppressor mutant strains of Escherichia coli respond either to suppression of signal peptide mutations or to blockage of staphylokinase processing.

Authors:  T Sako; T Iino
Journal:  J Bacteriol       Date:  1988-11       Impact factor: 3.490

2.  Novel prlA alleles defective in supporting staphylokinase processing in Escherichia coli.

Authors:  T Sako
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.